Concentrated stock positions are among the most consequential and most frequently deferred planning problems that wealth holders face. The reason they are deferred is almost always the same: the tax cost of selling feels too high. But deferral has its own cost — a cost that is invisible until something goes wrong.
A private transition-readiness assessment for major financial decisions.
The short answer: Concentration risk is not a judgment about the company — it is arithmetic about the household. When one stock is a quarter or more of investable assets, its volatility becomes the family's volatility, and single-name drawdowns of 50% are routine even among excellent companies. The risk compounds quietly until one event reprices it.
Direct Answer
There is no universally agreed threshold, but a position representing more than 10–20% of investable assets is typically considered concentrated for planning purposes. The more useful question is not 'how much' but what the cost and consequences of concentration are — and what it would actually take to diversify. The tax cost of reducing a concentrated position is real. But so is the risk of holding it, and the interaction between that position and the rest of your financial plan — income, estate, tax bracket — rarely receives the coordinated review it warrants.
Key Takeaways
There is no universal threshold for what counts as "concentrated," but a position above roughly 10–20% of investable assets is generally treated that way for planning purposes.
Concentration risk is idiosyncratic risk — the chance that one company's specific problems can materially damage an entire portfolio — and diversifying other assets does not offset it.
Tax-aware strategies exist for reducing a concentrated position gradually, including staged sales, exchange funds, charitable remainder trusts, donor-advised funds, and hedges like collars, but each involves tradeoffs among tax cost, speed, income, and control.
Using the tax cost of selling as a reason to defer indefinitely turns one factor in a broader tradeoff into an effective veto on ever addressing the position.
Concentrated positions are rarely reviewed as part of the whole financial picture — estate plan disposition, trading restrictions, and income or tax-bracket interactions are frequently left unexamined.
Left unmanaged, a concentrated position tends to become more concentrated over time rather than less, and the planning required only grows more complex as it does.
Common Blind Spots with Concentrated Positions
The tax cost of selling is used to justify indefinite deferral. Capital gains taxes on a concentrated sale are real and material. But they are not a reason to hold indefinitely — they are one factor in a tradeoff that also includes concentration risk, income needs, estate planning, and opportunity cost. Framing the tax cost as a veto on action tends to prevent the tradeoff from being evaluated clearly.
Estate planning around the position is not coordinated. A concentrated position has different value and planning implications if it will be held to death (step-up in basis), given to charity (deduction at FMV, no capital gains), or sold during lifetime. The estate plan should reflect the intended disposition of the position — and often does not.
Trading constraints not fully understood. Insider trading policies, 10b5-1 plan requirements, lock-up agreements, and Rule 144 volume limitations each constrain when and how a position can be reduced. Many holders have not reviewed the specific constraints that apply to their position.
Hedging introduces new complexity. Protective puts, collars, and prepaid variable forwards are strategies for managing the risk of a concentrated position without an immediate taxable sale. Each has cost, complexity, and IRS constructive sale considerations. They are planning tools with real tradeoffs, not simple solutions.
Emotional attachment is a planning input, not a reason to avoid planning. Many concentrated positions originated as founder shares, inherited stock, or employer grants. The emotional meaning of the position is legitimate information — but it should be named and weighed explicitly, not treated as a structural argument for maintaining the position indefinitely.
Income and tax bracket interaction not modeled. A large concentrated position affects estimated taxes, alternative minimum tax exposure (for ISO holders), net investment income tax, and Medicare surcharges. These interactions are frequently not modeled as a unified picture.
Questions to Ask About a Concentrated Position
What percentage of my total investable assets does this position represent — and how has that percentage changed over the past three years?
What are the specific trading constraints (insider policies, lock-up, 10b5-1 requirements) that apply to this position?
What is the estimated tax cost of a full liquidation — and how does spreading that over 3, 5, or 10 years affect the after-tax outcome?
What is my estate plan's intended disposition of this position, and does the plan reflect that intention?
If I am charitably inclined, what is the difference in outcome between donating the shares and donating cash proceeds?
What hedging strategies are available to me, and have the costs and tax implications been modeled?
Are my financial, tax, and legal advisors coordinating on a unified approach to this position?
What Often Gets Missed
The most common single error in concentrated position planning is not a wrong decision — it is the absence of any decision. The position sits, year after year, without a structured review of the tradeoffs, a defined strategy, or a clear disposition plan. This is not planning; it is inertia.
The second most common error is evaluating the tax cost of selling in isolation from the rest of the financial plan. The right comparison is not "sell and pay taxes vs. hold" — it is the full expected value of each path, including estate implications, income needs, diversification benefit, and the probability distribution of the stock's future performance.
Concentrated positions also have a tendency to become more concentrated over time, not less, if they are not actively managed. A position that represents 20% of a portfolio at 40 may represent 60% at 60 if the stock has performed well and no action has been taken. The planning required at 60% concentration is significantly more complex than at 20%.
A concentrated position is not primarily a question about the company's quality — it is a question about how much of the household's financial life depends on a single security's outcome. The tax cost of reducing it is real and immediate, but treating that cost as a reason to defer indefinitely ignores that the position tends to grow larger, not smaller, the longer it goes unaddressed. Because the available tax, estate, and hedging strategies each involve genuine tradeoffs rather than easy fixes, the most consistent error is not choosing the wrong strategy but never evaluating the tradeoff at all.
Axel Index
Understand the full planning picture around your concentrated position.
Concentrated wealth planning involves tax, estate, income, and coordination decisions that are rarely reviewed together. Axel helps identify which dimensions may be receiving less attention than they warrant.
A Rule 10b5-1 plan is a pre-established trading plan that allows corporate insiders to sell shares on a predetermined schedule, price, or volume basis — providing an affirmative defense against insider trading allegations. Plans must be established when the insider is not in possession of material non-public information and must meet specific timing and documentation requirements under SEC rules updated in 2023.
What is a charitable remainder trust?
A charitable remainder trust (CRT) is an irrevocable trust that allows a donor to contribute appreciated assets — including concentrated stock positions — to the trust, which then sells them without triggering immediate capital gains tax. The trust pays an income stream to the donor (or other beneficiaries) for a term or lifetime, with the remainder passing to a designated charity. CRTs are one of several tools for managing concentrated positions in a tax-aware way.
Should I use a donor-advised fund for my concentrated position?
Contributing appreciated shares directly to a donor-advised fund (DAF) eliminates capital gains tax on the contributed shares and generates a charitable deduction for the full fair market value (subject to AGI limits). This can be significantly more tax-efficient than selling the shares and donating the cash. DAFs are appropriate when the holder has philanthropic intent and wants to separate the tax decision from the grant-making decision.
What is the constructive sale rule for hedged positions?
The IRS constructive sale rules (IRC §1259) treat certain hedging transactions — particularly short sales against the box and total return swaps — as triggering a taxable event equivalent to a sale, even though the underlying shares were not sold. Not all hedging strategies trigger constructive sale treatment. Collars and protective puts are generally designed to avoid constructive sale characterization, but the specific terms matter and should be reviewed by a tax advisor.
What is Axel?
The Axel Index is an educational transition-readiness assessment designed to help individuals approaching major financial transitions — including those managing concentrated wealth — identify potential planning gaps. It does not provide financial, tax, or legal advice and does not replace professional planning.